Parnax Lab Balance Sheet Health
Financial Health criteria checks 4/6
Parnax Lab has a total shareholder equity of ₹791.0M and total debt of ₹660.0M, which brings its debt-to-equity ratio to 83.4%. Its total assets and total liabilities are ₹1.8B and ₹1.0B respectively. Parnax Lab's EBIT is ₹204.4M making its interest coverage ratio 4. It has cash and short-term investments of ₹16.8M.
Key information
83.4%
Debt to equity ratio
₹659.96m
Debt
| Interest coverage ratio | 4x |
| Cash | ₹16.76m |
| Equity | ₹790.96m |
| Total liabilities | ₹1.01b |
| Total assets | ₹1.80b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 506128's short term assets (₹618.8M) do not cover its short term liabilities (₹678.7M).
Long Term Liabilities: 506128's short term assets (₹618.8M) exceed its long term liabilities (₹332.9M).
Debt to Equity History and Analysis
Debt Level: 506128's net debt to equity ratio (81.3%) is considered high.
Reducing Debt: 506128's debt to equity ratio has reduced from 109.9% to 83.4% over the past 5 years.
Debt Coverage: 506128's debt is well covered by operating cash flow (33.4%).
Interest Coverage: 506128's interest payments on its debt are well covered by EBIT (4x coverage).